Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection -an Open Label Randomized Controlled Trial

NCT07010744 is registered in ClinicalTrials.gov with Akil Al Islam as lead sponsor.

NCT NCT07010744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07010744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection -an Open Label Randomized Controlled Trial
Lead sponsor
Akil Al Islam
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 1, 2025
Completion date
June 30, 2026
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspepsia